bioRxiv · 10.1101/2025.04.07.647596
A modular, Galaxy-based immunopeptidogenomic (iPepGen) analysis pipeline for discovery, verification, and prioritization of candidate cancer neoantigen peptides
Abstract
Characterizing tumor-specific neoantigen peptides, derived from genomic or transcriptomic aberrations and presented to the immune system, is critical for immuno-oncology studies. To this end, the modular iPepGen immunopeptidogenomics pipeline provides these functions: (1) Neoantigen prediction and protein database generation from genomic or transcriptomic sequencing data; (2) Peptide identification (3) Verification from immunopeptidomic mass spectral data; (4) Neoantigen classification and visualization; (5) Candidate prioritization for further study. Easy access via a publicly available, scalable cloud-based gateway coupled with online, interactive training materials streamlines the adoption by cancer researchers who require immunopeptidogenomic analysis tools but lack advanced computational expertise and resources.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Mehta, S., Wagner, R., Do, K. T., Johnson, J. E., Yu, F., Jubenville, T., Richards, K., Coleman, S., Popescu, F. E., Nesvizhskii, A. I., Largaespada, D. A., Jagtap, P. D., Griffin, T. J.. 2025-04-08. A modular, Galaxy-based immunopeptidogenomic (iPepGen) analysis pipeline for discovery, verification, and prioritization of candidate cancer neoantigen peptides. https://doi.org/10.1101/2025.04.07.647596
Cite the original work for its findings. Save a collection to share your selection of sources.